Funding for this research was provided by:
Japan Society for the Promotion of Science (17928985, 19K09478)
Text and Data Mining valid from 2020-02-05
Received: 3 December 2019
Accepted: 18 January 2020
First Online: 5 February 2020
Ethics approval and consent to participate
: The present study was approved by the institutional review board at Nagoya University Hospital (approval number: 2012–0067) and it complied with all provisions of the World Medical Association Declaration of Helsinki. Tumor samples of sequential diffuse midline glioma, H3 K27M-mutant cases that had undergone biopsy from February 2014 to March 2019 were collected intra-operatively upon receiving informed consent from the patients.
: Not applicable.
: The authors declare that they have no competing interests.